The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities von Assohou-Luty, Constance, Raijmakers, Reinout, Benckhuijsen, Willemien E., Stammen-Vogelzangs, Judith, de Ru, Arnoud, van Veelen, Peter A., Franken, Kees L.M.C., Drijfhout, Jan W., Pruijn, Ger J.M.

Volltext

Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy von Ogouyèmi-Hounto, Aurore, Damien, Georgia, Deme, Awa Bineta, Ndam, Nicaise T., Assohou, Constance, Tchonlin, Didier, Mama, Atika, Hounkpe, Virgile Olivier, Moutouama, Jules Doumitou, Remoué, Franck, Ndiaye, Daouda, Gazard, Dorothée Kinde

Volltext

Generation of a FasL-based Proapoptotic Fusion Protein Devoid of Systemic Toxicity due to Cell-surface Antigen-restricted Activation von Samel, Dierk, Müller, Dafne, Gerspach, Jeannette, Assohou-Luty, Constance, Sass, Gabriele, Tiegs, Gisa, Pfizenmaier, Klaus, Wajant, Harald

Volltext

A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95 von ASSOHOU-LUTY, Constance, GERSPACH, Jeanette, SIEGMUND, Daniela, MÜLLER, Nicole, HUARD, Bertrand, TIEGS, Gisa, PFIZENMAIER, Klaus, WAJANT, Harald

Volltext

Generation and characterization of CD40-Flag-FasL, a novel Fas agonist devoid of systemic toxicity

Volltext bestellen